Detalhe da pesquisa
1.
Sera Antibody Repertoire Analyses Reveal Mechanisms of Broad and Pandemic Strain Neutralizing Responses after Human Norovirus Vaccination.
Immunity
; 50(6): 1530-1541.e8, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216462
2.
Emergence of Novel Norovirus GII.4 Variant.
Emerg Infect Dis
; 30(1): 163-167, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38063078
3.
Secretor Status Strongly Influences the Incidence of Symptomatic Norovirus Infection in a Genotype-Dependent Manner in a Nicaraguan Birth Cohort.
J Infect Dis
; 225(1): 105-115, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129046
4.
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.
J Infect Dis
; 226(10): 1771-1780, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137154
5.
CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus.
PLoS Pathog
; 16(4): e1008242, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251490
6.
Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study.
BMC Med
; 19(1): 299, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753508
7.
Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
J Infect Dis
; 221(6): 919-926, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628848
8.
Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.
J Virol
; 93(2)2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355694
9.
Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
J Virol
; 92(11)2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540599
10.
Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape.
J Infect Dis
; 217(7): 1145-1152, 2018 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281104
11.
Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
J Infect Dis
; 215(6): 984-991, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453838
12.
Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.
J Infect Dis
; 216(10): 1227-1234, 2017 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28973354
13.
Resolution of diarrhea in an immunocompromised patient with chronic norovirus gastroenteritis correlates with constitution of specific antibody blockade titer.
Infection
; 44(4): 551-4, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825307
14.
Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
PLoS Med
; 12(3): e1001807, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25803642
15.
Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.
J Virol
; 88(2): 829-37, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173225
16.
Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
J Virol
; 88(13): 7256-66, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24741081
17.
Within-host evolution results in antigenically distinct GII.4 noroviruses.
J Virol
; 88(13): 7244-55, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24648459
18.
Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
J Virol
; 88(16): 8826-42, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24872579
19.
The state of norovirus vaccines.
Clin Infect Dis
; 58(12): 1746-52, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24585561
20.
Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.
J Virol
; 87(5): 2803-13, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269783